Atorvastatin Calcium
Product Images NDC 68071-4267

5 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-4267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including calcium ions. The image displays the molecular formula with phenyl groups, fluorine substitution, hydroxyl groups, and the calcium cation complexed to the compound.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph showing cumulative incidence (%) over time (years) comparing Atorvastatin and Placebo groups. The Atorvastatin group is represented by a solid line, and the Placebo by a dashed line, with the Placebo showing higher incidence over approximately 3.5 years. Hazard ratio (HR) and p-value are noted below the graph.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing cumulative hazard percentages over time for Placebo and Atorvastatin groups. The x-axis represents time to first primary endpoint in years (up to 5 years), and the y-axis shows cumulative hazard percentage. The placebo group is depicted with a dashed line and shows higher hazard, while the Atorvastatin group has a solid line indicating lower cumulative hazard, with a hazard ratio of 0.63 (0.48-0.83) and p=0.001.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing a cardiovascular event over five years between Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The graph shows time to first major cardiovascular endpoint in years on the x-axis and percent of subjects experiencing events on the y-axis, including a hazard ratio (HR 0.78, 95% CI 0.69-0.89) and p-value (0.0002).*
FDA Label Image

Pdp (68071 4267 9)

Pdp (68071 4267 9)
Label for Atorvastatin Calcium 40 mg tablets, 90 count, manufactured by Apotex Inc. and packaged by NuCare Pharmaceuticals, Inc. The label includes dosage form and strength, NDC 68071-4267, and instructions to see manufacturer’s label for full list of ingredients. It also includes storage instructions and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.